The Race for New Treatments for Graves Orbitopathy (Thyroid Eye Disease)
The Journal of Clinical Endocrinology & Metabolism · 16.09.2024 · 109 (10) · e1938-e1939
DOI: 10.1210/clinem/dgad693 ↗Kurz gefasst
Editorial in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 07.03.2024. Verfasst von Colin M Dayan. Beteiligte Einrichtung: Thyroid Research Group, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, UK. Hauptthemen laut MEDLINE: Graves Ophthalmopathy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Thyroid Research Group, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.
ORCID-Profile: Colin M Dayan
Zitieren
APA
Dayan, C. M. (2024). The Race for New Treatments for Graves Orbitopathy (Thyroid Eye Disease). The Journal of Clinical Endocrinology & Metabolism, 109(10), e1938-e1939. https://doi.org/10.1210/clinem/dgad693
Vancouver
Dayan CM. The Race for New Treatments for Graves Orbitopathy (Thyroid Eye Disease). The Journal of Clinical Endocrinology & Metabolism. 2024;109(10):e1938-e1939. doi:10.1210/clinem/dgad693
BibTeX
@article{Dayan2024,
author = {Dayan, Colin M},
title = {The Race for New Treatments for Graves Orbitopathy (Thyroid Eye Disease)},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
volume = {109},
number = {10},
pages = {e1938--e1939},
doi = {10.1210/clinem/dgad693}
}
EUVIMED